SCHEMBL2693722

SCHEMBL2693722

CCCCC1CCC(=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.50
TLR4 O00206 1/20 0.44
NOS1 P29475 2/20 0.41
NOS2 P35228 2/20 0.41
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
TP53 P04637 1/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
NAAA Q02083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6526063 1.00 CYP1A2 (0.50) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL2691363 0.94 CYP1A2 (0.58) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL22668960 0.92 CYP1A2 (0.56) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL20822308 0.92 CYP1A2 (0.56) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL20822215 0.92 CYP1A2 (0.56) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL11860794 0.92 CYP1A2 (0.56) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL6516575 0.88 CYP1A2 (0.52) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL918157 0.88 CYP1A2 (0.52) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL4864166 0.88 CYP1A2 (0.52) CYP1A2TLR4NOS1NOS2ALDH1A1
SCHEMBL6438527 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119752742-A Pre-harvest physiological management method for improving color and smell quality of spirulina 中国海洋大学 2025-04-04 CN disclosed
EP-4318629-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODES, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICES, AND SECONDARY BATTERY AGC INC. (JP) 2024-02-07 EP disclosed
US-20230420686-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODE, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICE, AND SECONDARY BATTERY AGC Inc. (JP) 2023-12-28 US disclosed
US-10607749-B2 Copolymer, method for its production, wire coating resin material and electric wire AGC Inc. (JP) 2020-03-31 US disclosed
EP-3330301-A1 COPOLYMER, METHOD FOR PRODUCING SAME, RESIN MATERIAL FOR ELECTRIC WIRE SHEATHING, AND ELECTRIC WIRE Asahi Glass Company, Limited (JP) 2018-06-06 EP disclosed
CN-107922543-A Copolymer, its manufacture method, electric wire coatings resin material and electric wire 旭硝子株式会社 2018-04-17 CN disclosed
US-20180061522-A1 COPOLYMER, METHOD FOR ITS PRODUCTION, WIRE COATING RESIN MATERIAL AND ELECTRIC WIRE ASAHI GLASS COMPANY, LIMITED (JP) 2018-03-01 US disclosed
CN-102471553-B Fluorine-containing copolymer composition and method for producing same ASAHI GLASS CO.,LTD. (JP) 2016-02-10 CN disclosed
CN-103739566-B Containing the chirality five-membered of sulphonamide and ring framework compound and preparation method and purposes Third Military Medical University, Chinese People's Liberation Army (CN) 2016-01-20 CN disclosed
EP-2450406-B1 FLUORINE-CONTAINING COPOLYMER COMPOSITION AND METHOD FOR PRODUCING SAME ASAHI GLASS CO LTD (JP) 2015-10-14 EP disclosed
US-20030125563-A1 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-07-03 US disclosed
US-6465664-B1 CATALYZED WITH A TRANSITION METAL CATALYST COMPOSED OF A COPPER COMPOUND AND AN ASYMMETRIC LIGAND, SUCH AS A PHOSPHINE, A NUCLEOPHILE AND A BASE MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2002-10-15 US disclosed
US-6410748-B1 Alicycli c group-containing monomer KABUSHIKI KAISHA TOSHIBA (JP) 2002-06-25 US disclosed
US-6291129-B1 LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS KABUSHIKI KAISHA TOSHIBA (JP) 2001-09-18 US disclosed
WO-2001019761-A2 ASYMMETRIC 1,4-REDUCTIONS OF AND 1,4-ADDITIONS TO ENOATES AND RELATED SYSTEMS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-03-22 WO disclosed
US-4410705-A Novel spiro oxazoline compounds and methods for their preparation and use ALLIED CORPORATION (US) 1983-10-18 US disclosed
US-4139717-A 1,3-Dicarbonyl compounds TEIJIN LIMITED (JP) 1979-02-13 US disclosed
US-4009196-A HYPOTENSIVE AGENTS, BRONCHODILATORS, PROSTAGLANDIN ANALOGS TEIJIN LIMITED (JA) 1977-02-22 US disclosed
US-3954984-A ANTISECRETRETORY AGENTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS RICHARDSON-MERRELL INC. (US) 1976-05-04 US disclosed
US-3954981-A Triazolocycloalkylhydrothiadiazine derivatives RICHARDSON-MERRELL INC. (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125563-A1 Asymmetric 1,4-reductions of and 1,4-additions to enoates and related systems APEX1, AP2A1, ENPP1 CYP1A2 1138/4885TLR4 3155/4885NOS1 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.